These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 7515996)

  • 21. Interactions of the enantiomers of 3-O-methyldobutamine with alpha- and beta-adrenoceptors in vitro.
    Ruffolo RR; Messick K; Horng JS
    Naunyn Schmiedebergs Arch Pharmacol; 1985 May; 329(3):244-52. PubMed ID: 2991776
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Response of the atrial pacemaker to dobutamine.
    Puntoni de Mikulić LE; Márquez MT; Aramendía P
    Acta Physiol Lat Am; 1977; 27(3):108-13. PubMed ID: 210632
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vitro pharmacological properties of a series of isoprenaline derivatives.
    Eigenmann R; Burkard WP; Holck M; Märki HP; Osterrieder W; Goodman M; Melmon KL
    Arzneimittelforschung; 1989 Aug; 39(8):842-7. PubMed ID: 2554933
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vitro study of a novel atypical beta-adrenoceptor agonist, SM-11044.
    Sugasawa T; Matsuzaki M; Morooka S; Foignant N; Blin N; Strosberg AD
    Eur J Pharmacol; 1992 Jun; 216(2):207-15. PubMed ID: 1356795
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The sympathomimetic activity of N-isopropyloctopamine in vitro.
    Anderson WG
    J Pharmacol Exp Ther; 1983 Jun; 225(3):553-8. PubMed ID: 6306210
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cardiovascular hybrid drugs: new benzazepinone derivatives as bradycardic agents endowed with selective beta1-non-competitive antagonism.
    Bisi A; Rampa A; Budriesi R; Gobbi S; Belluti F; Ioan P; Valoti E; Chiarini A; Valenti P
    Bioorg Med Chem; 2003 Apr; 11(7):1353-61. PubMed ID: 12628661
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Comparative study between dobutamine and other catecholamines in their effects on the cardiac contraction and rhythm (author's transl)].
    Ueda M; Matsumura S; Matsuda S; Kawakami M; Morishige E
    Nihon Yakurigaku Zasshi; 1977 May; 73(4):501-16. PubMed ID: 20396
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Further evidence for a homogeneous population of beta-1-adrenoceptors in bovine coronary artery.
    Purdy RE; Stupecky GL; Coulombe PR
    J Pharmacol Exp Ther; 1988 Apr; 245(1):67-71. PubMed ID: 2834547
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Catecholaminergic and muscarinergic receptors in chronic experimental uremia.
    Lübbecke F; Steudle V; Schütterle G; Wizemann V
    Clin Physiol Biochem; 1989; 7(3-4):149-60. PubMed ID: 2553318
    [TBL] [Abstract][Full Text] [Related]  

  • 30. I. Pharmacological studies with derivatives of 2-aminotetralin, benzhydro[f]quinoline and clonidine suggest a pharmacological identity between peripheral and central alpha-2 adrenoceptors.
    Maixner W; Verimer T; Zeit-Har MS; Cannon JG; Long JP
    J Pharmacol Exp Ther; 1983 Feb; 224(2):346-51. PubMed ID: 6296356
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Stimulation of beta-adrenoceptors by dobutamine in the guinea-pig atrium and tracheal chain.
    Wagner J; Schümann HJ
    Naunyn Schmiedebergs Arch Pharmacol; 1979 Jul; 308(1):19-23. PubMed ID: 40138
    [No Abstract]   [Full Text] [Related]  

  • 32. Activity of N-(phenethyl)phenylethanolamines at beta(1) and beta(2) adrenoceptors: structural modifications can result in selectivity for either subtype.
    Urtishak K; McCafferty G; Zaratin P; Scheideler M; Grugni M; Artico M; Hieble JP
    Pharmacology; 2001 Feb; 62(2):113-8. PubMed ID: 11174082
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Catecholamine transport in isolated lung parenchyma of pig.
    Goldie RG; Paterson JW
    Br J Pharmacol; 1982 Aug; 76(4):507-13. PubMed ID: 7104521
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Mode of action of catecholamine on the myocardial cells (author's transl)].
    Goto M; Hyôdo T; Hachisuga M
    Kokyu To Junkan; 1981 Jul; 29(7):683-91. PubMed ID: 6270756
    [No Abstract]   [Full Text] [Related]  

  • 35. Differential activation of beta 1-, beta 2- and beta 3-adrenoceptors by catecholamines in white and brown adipocytes.
    Galitzky J; Carpéné C; Bousquet-Mélou A; Berlan M; Lafontan M
    Fundam Clin Pharmacol; 1995; 9(4):324-31. PubMed ID: 8566931
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sensitivity changes of adrenergic -receptors of isolated ileum and trachea preparations induced by alteration of temperature.
    Wagner J; Reinhardt D; Schümann HJ
    Arch Int Pharmacodyn Ther; 1972 Jun; 197(2):290-300. PubMed ID: 4402301
    [No Abstract]   [Full Text] [Related]  

  • 37. Heterogeneity of postsynaptic Alpha adrenergic receptors in mammalian aortas.
    Ruffolo RR; Waddell JE; Yaden EL
    J Pharmacol Exp Ther; 1982 May; 221(2):309-14. PubMed ID: 6281411
    [No Abstract]   [Full Text] [Related]  

  • 38. [Patterns in the inhibition of adrenergic response by catecholamines].
    Nesterov LA; Manukhin BN
    Fiziol Zh SSSR Im I M Sechenova; 1983 Aug; 69(8):1031-6. PubMed ID: 6628746
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparative aspects of adrenergic receptors in the hearts of lower vertebrates.
    Ask JA
    Comp Biochem Physiol A Comp Physiol; 1983; 76(3):543-52. PubMed ID: 6139225
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Potency and selectivity in vitro of compounds related to isoprenaline and orciprenaline on beta-adrenoceptors in the guinea-pig.
    O'Donnell SR; Wanstall JC
    Br J Pharmacol; 1974 Nov; 52(3):407-17. PubMed ID: 4458848
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.